Citations 6

Biophysical Analyses of Synthetic Amyloid-β(1−42) Aggregates before and after Covalent Cross-Linking. Implications for Deducing the Structure of Endogenous Amyloid-β Oligomers

Biochemistry | November 6, 2009 | Volume: 48 | Issue: 49 | Pages: 11796-11806

10.1021/bi901571t | PMID 19916493

Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity

Proceedings of the National Academy of Sciences | April 21, 2009 | Volume: 106 | Issue: 18 | Pages: 7607-7612

10.1073/pnas.0900688106 | PMID 19383787

Inclusions of TAR DNA-binding protein-43 (TDP-43), a nuclear protein that regulates transcription and RNA splicing, are the defining histopathological feature of frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-Us) and sporadic and familial forms of amyotrophic lateral sclerosis (ALS). In ALS and FTLD-U, aggregated, ubiquitinated, and N-terminally truncated TDP-43 can be isolated from brain tissue rich in neuronal and glial cytoplasmic inclusions. The loss of TDP-43 function resulting from inappropriate cleavage, translocation from the nucleus, or its sequestration into inclusions could play important roles in neurodegeneration. However, it is not known whether TDP-43 fragments directly mediate toxicity and, more specifically, whether their abnormal aggregation is a cause or consequence of pathogenesis. We report that the ectopic expression of a ≈25-kDa TDP-43 fragment corresponding to the C-terminal truncation product of caspase-cleaved TDP-43 leads to the formation of toxic, insoluble, and ubiquitin- and phospho-positive cytoplasmic inclusions within cells. The 25-kDa C-terminal fragment is more prone to phosphorylation at S409/S410 than full-length TDP-43, but phosphorylation at these sites is not required for inclusion formation or toxicity. Although this fragment shows no biological activity, its exogenous expression neither inhibits the function nor causes the sequestration of full-length nuclear TDP-43, suggesting that the 25-kDa fragment can induce cell death through a toxic gain-of-function. Finally, by generating a conformation-dependent antibody that detects C-terminal fragments, we show that this toxic cleavage product is specific for pathologic inclusions in human TDP-43 proteinopathies.
P2‐347: BRI2 (ITM2B) inhibits Aβ deposition

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_14 | Pages: No page available

10.1016/j.jalz.2008.05.1424

P2‐338: Substrate‐targeting gamma‐secretase modulators

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_14 | Pages: No page available

10.1016/j.jalz.2008.05.1415

Amyloid-β(1−42) Rapidly Forms Protofibrils and Oligomers by Distinct Pathways in Low Concentrations of Sodium Dodecylsulfate

Biochemistry | October 2, 2007 | Volume: 46 | Issue: 43 | Pages: 12451-12462

10.1021/bi701213s | PMID 17910477

Secondary Structure and Interfacial Aggregation of Amyloid-β(1−40) on Sodium Dodecyl Sulfate Micelles

Biochemistry | June 22, 2006 | Volume: 45 | Issue: 28 | Pages: 8639-8648

10.1021/bi060323t | PMID 16834338